Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Klin Padiatr ; 228(1): 42-6, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26697738

ABSTRACT

BACKGROUND: Population-based data on pediatric patients on long-term respiratory support (LTRS) in Austria are lacking. This study aimed to record the pediatric departments active in this field, as well as number and characteristics of patients on LTRS. METHODS: A national cross-sectional study was carried out by means of questionnaires sent to all pediatric departments in Austria. RESULTS: All departments answered to the questionnaires. On June 1st, 2013, the reference day for this study, 12 of the 41 pediatric departments in Austria were active in the field. At this time, these centers were caring for 143 patients, 111 (77.6%) of them under 18 years, which corresponds to a prevalence of 7.4 per 100 000. The patients suffered from neuromuscular disorders (44%), other neurological disorders (18.9%), disorders of respiratory drive (9.1%), obstructive sleep apnea (8.4%), thoracal and spinal diseases (8.4%), pulmonary disorders (4.9%) and other diseases (6.3%). Continuous positive airway pressure was used in 6.3%, non-invasive ventilation in 60.1% and invasive ventilation in 33.6% of the patients, respectively. LTRS was performed at home in 92.3%. CONCLUSION: LTRS represents a common management strategy in children and adolescents with a variety of disorders. Census reports such as this one provide the basis for appropriate planning of resource allocation. The age distribution of our patients shows the need for structured transition into adult care.


Subject(s)
Long-Term Care/methods , Long-Term Care/trends , Respiration, Artificial/statistics & numerical data , Respiratory Insufficiency/therapy , Adolescent , Austria , Child , Child, Preschool , Chronic Disease , Cross-Sectional Studies , Female , Home Care Services, Hospital-Based/statistics & numerical data , Home Care Services, Hospital-Based/trends , Humans , Infant, Newborn , Long-Term Care/statistics & numerical data , Male , Respiratory Insufficiency/epidemiology , Respiratory Insufficiency/etiology , Surveys and Questionnaires , Utilization Review/statistics & numerical data
2.
Klin Padiatr ; 223(5): 276-9, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21630179

ABSTRACT

BACKGROUND: Thermal stress is a risk factor for sudden infant death syndrome (SIDS). Recently, baby sleeping bags have been recommended as a preventive measure against SIDS. The aim of this study was to describe in which way the use of baby sleeping bags might influence thermoregulation of sleeping infants and maybe the incidence of SIDS. METHODS: Body surface temperature was recorded by use of infrared thermography in 15 infants (median age 49 days). Recordings were done twice: after sleeping for 60 min under a blanket and after sleeping for 60 min in a baby sleeping bag. Temperature was recorded and compared for defined sites of body surface. RESULTS: Infants' mean body surface temperature as well as core temperature after sleeping in a baby sleeping bag did not show significant differences when compared to infants sleeping under a conventional blanket. CONCLUSION: Under controlled conditions, core temperature and mean body surface temperature are comparable, equally if using a baby sleeping bag or conventional bedding. However, under the more uncontrolled conditions of baby care at home, sleeping bags might provide a more constant temperature profile, while other bedding conditions may lead to significant variations of temperature pattern.


Subject(s)
Body Temperature Regulation/physiology , Skin Temperature/physiology , Sudden Infant Death/prevention & control , Thermography , Austria , Bedding and Linens , Cross-Sectional Studies , Female , Humans , Infant , Infant, Newborn , Male , Sudden Infant Death/epidemiology
3.
Scand J Med Sci Sports ; 21(6): e100-5, 2011 Dec.
Article in English | MEDLINE | ID: mdl-20636306

ABSTRACT

Ghrelin is a peptide hormone, which plays an important role in appetite regulation. The effects of exercise on ghrelin plasma concentrations are still not clear, especially in children and adolescents. The aim of this study was to investigate the response of acylated and total ghrelin concentrations to controlled exercise in school-aged children. Thirty-six healthy school-aged children (mean age 12.61 years, SD ± 0.39) underwent a controlled bicycle exercise test. Before and immediately after exercise, blood samples were taken in order to measure plasma ghrelin concentrations. The control group consisted of 24 healthy school-aged children. After controlled short-time exercise, total ghrelin concentrations showed no significant difference, whereas acylated ghrelin concentrations increased significantly (P<0.001) in the study population compared with the control group. Moreover, we found a correlation between the proportional increase of acylated ghrelin and the duration of exercise (P<0.01), and between the proportional increase of acylated ghrelin and maximal performance (P<0.01). Increased levels of acylated ghrelin after exercise could be a physiological response to ensure a sufficient caloric intake after energy consumption in children and adolescents.


Subject(s)
Exercise/physiology , Ghrelin/metabolism , Acylation , Adolescent , Austria , Child , Exercise Test/methods , Female , Ghrelin/blood , Humans , Male
4.
Ann Oncol ; 19(4): 807-13, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18056650

ABSTRACT

BACKGROUND: The aim of this study was to evaluate feasibility and toxicity of bevacizumab (Avastin), a monoclonal antibody directed against the vascular endothelial growth factor in children and young adults. PATIENTS AND METHODS: Fifteen patients (male: n = 8; female: n = 7; median age, 14.6 years) received bevacizumab for recurrent or progressive solid tumors (carcinoma: n = 3; neuroblastoma: n = 2; astrocytoma grade III: n = 2; rhabdomyosarcoma: n = 2; nephroblastoma: n = 2; benign vascular tumors: n = 2; synovial sarcoma: n = 1; and malignant hemangiopericytoma: n = 1) on a compassionate basis. Bevacizumab was administered at 5-10 mg/kg body weight intravenously every 2-3 weeks. Most patients received chemotherapy in addition to bevacizumab. Duration of bevacizumab therapy ranged from 1.5 to 23 months. RESULTS: Bevacizumab-related side-effects were mild and included hypertonia (n = 2), proteinuria/hematuria (n = 2), epistaxis (n = 2), local erythema (n = 1), and defective wound healing and ascites (n = 1). Radiographic objective responses (partial responses) were observed in two patients with astrocytoma grade III and in one patient each with neuroblastoma and pleomorphic rhabdomyosarcoma, respectively. CONCLUSIONS: Bevacizumab seems to have a good acute safety profile and some antitumor activity in heavily pretreated children and young adults with recurrent solid tumors. Prospective clinical trials are urgently needed to further evaluate the safety and efficacy of bevacizumab in pediatric patients.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal/therapeutic use , Neoplasms/drug therapy , Adolescent , Adult , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal, Humanized , Astrocytoma/drug therapy , Bevacizumab , Brain Neoplasms/drug therapy , Carcinoma/drug therapy , Child , Drug Administration Schedule , Empathy , Female , Humans , Kidney Neoplasms/drug therapy , Male , Neoplasm Recurrence, Local/drug therapy , Neuroblastoma/drug therapy , Retrospective Studies , Rhabdomyosarcoma/drug therapy , Sarcoma/drug therapy , Tomography, X-Ray Computed , Wilms Tumor/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...